Bessemer Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bessemer Group’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,715	Closed	-$232K	–	1843
2019 Q2	$232K	Sell	2,715 -202	-7%	-$20K	﹤0.01%	1048
2019 Q1	$315K	Buy	2,917 +1,994	+216%	+$199K	﹤0.01%	904
2018 Q4	$78K	Buy	923 +15	+2%	+$1.45K	﹤0.01%	1210
2018 Q3	$89K	Hold	908	–	–	﹤0.01%	1146
2018 Q2	$105K	Sell	908 -1,250	-58%	-$137K	﹤0.01%	1107
2018 Q1	$213K	Hold	2,158	–	–	﹤0.01%	997
2017 Q4	$226K	Buy	2,158 +55	+3%	+$6.04K	﹤0.01%	994
2017 Q3	$237K	Buy	2,103 +20	+1%	+$2.18K	﹤0.01%	1028
2017 Q2	$234K	Buy	2,083 +1,210	+139%	+$137K	﹤0.01%	1032
2017 Q1	$102K	Hold	873	–	–	﹤0.01%	1197
2016 Q4	$92K	Buy	+873	New	+$91.4K	﹤0.01%	1235

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Bessemer Group's TARO Position: Q3 2019 in Review

Bessemer Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2019, closing a stake of 2,715 shares — an estimated $232K sold.

Bessemer Group first reported a position in TARO in Q4 2016 and held it in 11 quarters. The position peaked at $315K in Q1 2019. 101 funds tracked by Wall St. Rank hold TARO as of Q3 2019.

Bessemer Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2019 after selling out during the quarter.
Bessemer Group sold 2,715 Taro Pharmaceutical Industries Ltd. shares in Q3 2019, an estimated $232K.
Bessemer Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 11 quarters.
Bessemer Group's Taro Pharmaceutical Industries Ltd. position peaked at $315K in Q1 2019.
101 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2019.

Based on Bessemer Group's 13F filing for Q3 2019, filed 7 Nov 2019.